DK1889607T3 - Injicerbar flydende paracetamol-formulering - Google Patents

Injicerbar flydende paracetamol-formulering

Info

Publication number
DK1889607T3
DK1889607T3 DK07112327T DK07112327T DK1889607T3 DK 1889607 T3 DK1889607 T3 DK 1889607T3 DK 07112327 T DK07112327 T DK 07112327T DK 07112327 T DK07112327 T DK 07112327T DK 1889607 T3 DK1889607 T3 DK 1889607T3
Authority
DK
Denmark
Prior art keywords
paracetamol
solution
injectable liquid
paracetamol formulation
liquid paracetamol
Prior art date
Application number
DK07112327T
Other languages
Danish (da)
English (en)
Inventor
Munoz Faustino Huertas
Plagaro Raul Fernandez
Original Assignee
Genfarma Lab S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38474429&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1889607(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genfarma Lab S L filed Critical Genfarma Lab S L
Application granted granted Critical
Publication of DK1889607T3 publication Critical patent/DK1889607T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
DK07112327T 2006-07-18 2007-07-12 Injicerbar flydende paracetamol-formulering DK1889607T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES2006/070108 WO2008009756A1 (es) 2006-07-18 2006-07-18 Formulación líquida inyectable de paracetamol

Publications (1)

Publication Number Publication Date
DK1889607T3 true DK1889607T3 (da) 2009-07-27

Family

ID=38474429

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07112327T DK1889607T3 (da) 2006-07-18 2007-07-12 Injicerbar flydende paracetamol-formulering

Country Status (17)

Country Link
US (2) US9943479B2 (ja)
EP (2) EP2100596A3 (ja)
JP (1) JP4929352B2 (ja)
AT (1) ATE432690T1 (ja)
AU (2) AU2006346318B2 (ja)
CA (1) CA2628806C (ja)
CY (1) CY1110480T1 (ja)
DE (1) DE602007001215D1 (ja)
DK (1) DK1889607T3 (ja)
ES (1) ES2327286T3 (ja)
HR (1) HRP20090350T1 (ja)
MA (1) MA31346B1 (ja)
PL (1) PL1889607T3 (ja)
PT (1) PT1889607E (ja)
RU (1) RU2419421C2 (ja)
SI (1) SI1889607T1 (ja)
WO (1) WO2008009756A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926992B1 (fr) * 2008-02-06 2011-01-14 Moly Pharma Formulation d'une solution de paracetamol injectable,procede de preparation et de conditionnement d'une telle solution et dispositif de conditionnement d'une telle solution
EP2243477A1 (de) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
US8404748B2 (en) 2009-08-13 2013-03-26 Neogen N.V. Storage-stable formulation of paracetamol in aqueous solution
IN2012DN05192A (ja) 2010-01-21 2015-10-23 Aprea Ab
PT2377516E (pt) 2010-04-14 2012-07-02 Braun Melsungen Ag Composição acetaminofeno
ES2414557B1 (es) 2012-01-16 2014-06-10 Novocat Farma, S.A. Composición acuosa de paracetamol para inyección
ITMI20121154A1 (it) * 2012-06-29 2013-12-30 Sint Sa Soluzione iniettabile di acetaminofene per la somministrazione spinale
ZA201300398B (en) * 2012-11-27 2013-09-25 Genfarma Laboratories S L Injectable liquid formulation of the combination of tramadol and paracetamol
US20140303254A1 (en) * 2013-04-08 2014-10-09 InnoPharma Licensing LLC Process Of Manufacturing A Stable, Ready To Use Infusion Bag For An Oxidation Sensitive Formulation
BR102014005885B1 (pt) * 2014-03-13 2021-04-13 Biotec Biológica Indústria Farmacêutica Ltda E.P.P Formulação farmacêutica líquida injetável estável de paracetamol em bolsa plástica pronta para uso
US20170202793A1 (en) * 2014-07-25 2017-07-20 Terumo Kabushiki Kaisha Packaged acetaminophen injection solution preparation
MX2018009497A (es) * 2016-02-05 2019-05-06 Innopharma Inc Proceso para fabricar una bolsa de infusion estable, lista para su uso para una formulacion sensible a la oxidacion.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440815A (en) 1981-06-29 1984-04-03 Abbott Laboratories Clear, autoclavable plastic formulation for medical liquid containers
FR2751875B1 (fr) 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
KR100226191B1 (ko) 1997-04-03 1999-10-15 구광시 음료용 플라스틱 병
DE69840028D1 (de) * 1997-10-23 2008-10-30 Morinaga Milk Industry Co Ltd Verfahren sowie vorrichtung zur kontiuierlichen hitzesterilisierung von fluessigkeiten
SI1285667T1 (sl) 1997-11-18 2006-10-31 Uni Pharma Kleon Tsetis Pharmaceutical Lab Sa Farmacevtske raztopine za injiciranje paracetamola ali kombinacij paracetamola z drugimi aktivnimi substancami
IT1301976B1 (it) 1998-07-31 2000-07-20 Angelini Ricerche Spa Composizione farmaceutica iniettabile a base di paracetamolo
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
DE10112325A1 (de) 2001-03-13 2002-10-02 Fresenius Kabi De Gmbh Lagerstabile Fertiginfusionslösungen des Paracetamols
ITMI20012135A1 (it) * 2001-10-16 2003-04-16 Bioren S A Soluzioni iniettabili pronte all'uso di paracetamolo
HUP0402549A3 (en) 2001-12-18 2006-01-30 Tseti Ioulia Parenteral composition of paracetamol
CA2487450C (en) * 2002-05-27 2009-09-22 Kyorin Pharmaceutical Co., Ltd. (2s)-2-ethylphenylpropanoic acid derivatives
WO2004004705A2 (en) 2002-07-03 2004-01-15 Shannon Biotechnology Ltd Pharmaceutical formulations for preparing drink products
FR2851164B1 (fr) 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
FR2862872A1 (fr) 2003-12-02 2005-06-03 Palbian Snc Composition a l'etat aqueux pour l'application perfusable d'un principe actif, notamment pharmacologique tel que le paracetamol.
US20060292225A1 (en) 2005-06-24 2006-12-28 Felix Arthur M Water soluble analgesic formulations and methods for production

Also Published As

Publication number Publication date
AU2006346318B2 (en) 2011-02-10
US20090215903A1 (en) 2009-08-27
AU2011201253B2 (en) 2012-03-29
US20160199325A1 (en) 2016-07-14
US9943479B2 (en) 2018-04-17
ES2327286T3 (es) 2009-10-27
JP2009543851A (ja) 2009-12-10
US9943492B2 (en) 2018-04-17
SI1889607T1 (sl) 2009-10-31
MA31346B1 (fr) 2010-05-03
EP1889607B1 (en) 2009-06-03
RU2009105480A (ru) 2010-08-27
HRP20090350T1 (en) 2009-08-31
AU2011201253A1 (en) 2011-04-07
PT1889607E (pt) 2009-07-20
PL1889607T3 (pl) 2009-10-30
RU2419421C2 (ru) 2011-05-27
DE602007001215D1 (de) 2009-07-16
CY1110480T1 (el) 2015-04-29
AU2006346318A1 (en) 2008-01-24
CA2628806C (en) 2012-08-21
WO2008009756A1 (es) 2008-01-24
EP1889607A1 (en) 2008-02-20
ATE432690T1 (de) 2009-06-15
EP2100596A3 (en) 2010-04-28
EP2100596A2 (en) 2009-09-16
JP4929352B2 (ja) 2012-05-09
CA2628806A1 (en) 2008-01-24

Similar Documents

Publication Publication Date Title
DK1889607T3 (da) Injicerbar flydende paracetamol-formulering
EA201070001A1 (ru) Водная композиция, содержащая соль, способ её получения и применения
CL2013002692A1 (es) Soluciones estabilizadas de acido hipohaloso y una cantidad estabilizadora de carbono inorganico disuelto; y metodo de preparacion de la misma.
TW200605872A (en) Alcohol-metabolism enhancing composition and ingesta containing the same
AR078885A2 (es) Composiciones estabilizadas de proteinas que tienen un radical tiol libre. recipiente impermeable. metodo.
EA201391317A1 (ru) Стабильная композиция хлорноватистой кислоты, способы ее получения и применение
DK2010014T3 (da) Solubilisater af konserveringsmidler og fremgangsmåde til fremstilling heraf
BRPI0706966A8 (pt) Composição para um efeito microbicida em um sistema de água, método para estabilizar cloro para ser utilizado como um biocida no tratamento de água em um sistema de processamento, e método para tratar um sistema de água de processamento de papel
TW200633951A (en) Method for reducing cyclohexenone content of a cyclohexenone-containing organic mixture
ATE367167T1 (de) Aufbereitung von aldesleukin zur pharmazeutischen verwendung
MX2010011890A (es) Formulacion de proteina.
DE60224449D1 (de) Gebrauchsfertige paracetamol injektionslösungen enthaltend propylenglykol als einziges cosolvens
SG159481A1 (en) Stabilization of thermolysin in aqueous solution
EA200800788A1 (ru) Фунгицидные смеси на основе триазолов
BRPI0513244A (pt) composto de clatrato, método para controlar a concentração de solução aquosa de ingrediente ativo quìmico agrìcola e formulação quìmica agrìcola
DE50209881D1 (de) Herstellung von dialysekonzentrat aus einer hochverdichteten konzentratvorstufe und vorrichtung zur anwendung am dialyseplatz.
BR112012018427A8 (pt) Uso de composto, e, método para aumentar o ph de uma suspensão aquosa
DE602004007762D1 (de) Herbizide zusammensetzung und verwendung
TH84738B (th) การใช้ 1-ฟีน็อกซี-2-โพรพานอล(1-phenoxy-2-propanol)เป็นตัวช่วยสูตรสีย้อม
RS51179B (sr) Tečne injektabilne formulacije paracetamola
Li Simultaneous determination of phthalate esters by micelle capillary electrophoresis
ES2570964T3 (es) Solución acuosa mixta de L-lisina y L-treonina
TH84738A (th) การใช้ 1-ฟีน็อกซี-2-โพรพานอล(1-phenoxy-2-propanol)เป็นตัวช่วยสูตรสีย้อม
UA117077U (uk) Спосіб стабілізації фармацевтичного складу для ін'єкцій, який містить 2-етил-6-метил-3-оксипіридину сукцинат
TH164819A (th) องค์ประกอบให้ความคงตัวที่มีส่วนประกอบของสารประกอบโครแมนที่มีการแทนที่และวิธีการใช้